Last reviewed · How we verify

NCT03970213

Intravenous Tranexamic Acid During Rhytidectomy

Status unknown Phase 4 Last updated 31 May 2019
What this trial tests

Phase 4 trial testing Tranexamic Acid 100Mg/Ml Inj Vil 10Ml in Bleeding in 40 participants. Status unknown.

Timeline
30 May 2019
Primary endpoint
30 August 2019
30 August 2019

Quick facts

Lead sponsorGlasgold Group Plastic Surgery
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment40
Start date30 May 2019
Primary completion30 August 2019
Estimated completion30 August 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Glasgold Group Plastic Surgery

Who can join

Adults 40 to 80, any sex, with Bleeding or Bruising Face. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on rhytidectomy surgery, or the subsequent postoperative sequelae. Intraoperative bleeding and postoperative ecchymosis and edema are subjectively rated and complications are noted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

Trials testing the same drug.

Other recruiting trials for Bleeding

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03970213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing